Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01195051 · ClinicalTrials.gov registry record · Phase 3
Medication Reconciliation Technology to Improve Quality of Transitional Care
A Phase 3 study, sponsored by Indiana University.
- Completed
- Registry status
- Phase 3
- Development phase
- 4,818
- Enrollment target
NCT01195051 is a Phase 3 study that has completed, run by Indiana University. The registered enrollment target is 4,818 participants.
The verdict
NCT01195051, a Phase 3 study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 4,818 participants
- Enrollment target
Study Summary
This study addresses the problem of inadequate medication reconciliation as patients cross boundaries between inpatient and outpatient care (ambulatory care). The purpose of this study is to determine whether a new, computer-based application, integrated with electronic prescribing, improves erroneous discrepancies between pre-hospital medications and medications upon patients' return to ambulatory care.
Interventions
- OTHER Electronic medication reconciliation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4,818 participants |
| Start Date | 2010-11 |
| Est. Completion | 2012-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01195051
The ClinicalTrials.gov registry entry for NCT01195051 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 4,818 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Electronic medication reconciliation is the first listed.
NCT01195051 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01195051 about?
NCT01195051 is a clinical study titled "Medication Reconciliation Technology to Improve Quality of Transitional Care". This study addresses the problem of inadequate medication reconciliation as patients cross boundaries between inpatient and outpatient care (ambulatory care). The purpose of this study is to determine whether a new, computer-based application, integrated with electronic prescribing, improves erroneo...
What is the current status of trial NCT01195051?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 4,818 participants. The study started on 2010-11. Estimated completion is 2012-04.
What interventions are being tested in trial NCT01195051?
The interventions under investigation include: Electronic medication reconciliation (OTHER).
Who is sponsoring clinical trial NCT01195051?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.